Programme

12th PACTRIMS CONGRESS THEMES

  1. Biomarkers in MS and NMOSD
  2. Molecular Neuropathology and Neuroimaging
  3. Rehabilitation and Regeneration
  4. Current and Emerging Therapeutic Approaches

 

Wednesday, 13 November 2019
Main Ballroom
13:30-15:00 European Charcot Foundation Symposium
B cell targeting therapy in MS and NMOSD
1. Pathological contribution of B cells in MS
2. Immunological contribution of B cells in MS
3. B cells in NMOSD
4. Present and future of B cell targeting therapy
15:00-15:30 Coffee Break
15:30-15:45 Opening Ceremony
15:45-17:15 Opening Lecture Series
Opening Lecture-1
L-1 Cellular and molecular mechanisms that orchestrate inflammation during both viral and autoimmune encephalitides via endothelial-immune cell interactions
Opening Lecture-2
L-2 From immuno-ablation to Neuro-repair: have cell-based therapies for MS come of age?
17:15-17:30 Coffee Break & Poster Viewing
17:30-19:00 Sponsored Symposium-1
19:30-21:00 Welcome Reception

 

Thursday, 14 November 2019
Main Ballroom
08:30-10:00 Sponsored Symposium-2
10:00-10:30 Coffee Break
10:30-11:50 Oral Presentation-1
Clinical Neurology Session
11:50-12:50 Lunch & Poster Viewing
12:50-14:50 Symposium-1
Molecular Neuropathology and Neuroimaging
L-3 Molecular neuropathology of multiple sclerosis
L-4 Glial pathology of MS and NMOSD
L-5 Imaging remyelination in MS: a validated biomarker of lesion repair?
L-6 B cells and regulatory plasma cells in CNS inflammation and autoimmunity
14:50-15:50 Coffee Break & Poster Review
15:50-17:10 Plenary Lectures
Rehabilitation and Regeneration for Demyelinating Diseases
L-12 Rehabilitation of MS: neuroplasticity and neuroregeneration vs compensation and coping
L-13 Repair strategies for progressive MS
17:10-17:30 Coffee Break
17:30-19:00 Sponsored Symposium-3
19:30-23:00 Presidential Dinner

 

Thursday, 14 November 2019
Breakout Session
12:50-15:20 Symposium-2
Basic Immunology in MS and NMOSD
L-7 T cells in MS
L-8 B cells in MS
L-9 Biomarkers for MS/NMOSD
L-10 Gut immune cells
L-11 Gut microbiome in autoimmune disorders: Insights from the study of NMOSD patients of Indian origin
15:20-15:40 Coffee Break & Poster Review
15:40-17:10 Nursing issues in MS/NMOSD and a patient-support activity session

 

Friday, 15 November 2019
Main Ballroom
08:30-10:00 Sponsored Symposium-4
10:00-10:30 Coffee Break & Poster Review
10:30-12:30 Symposium-3
Current and emerging therapeutic approaches
L-14 Present and future of B cell targeting therapy
L-15 Immune reconstitution following DMT: the devil is in the detail
L-16 Neuromyelitis optica spectrum disorders: at the vascular-immunology borderlands
L-17 Neuromyelitis optica spectrum disorders: short, medium and long term treatment paradigms
12:30-12:40 Closing and Award Ceremony

 

Friday, 15 November 2019
Breakout Session
12:50-15:20 Symposium-4
Biomarkers and Diagnosis in MS and NMOSD
L-18 Diagnostic use of metabolomics in multiple sclerosis and its mimics
L-19 The eyes have it: a clinician’s window on inflammatory brain disease
L-20 Lumpers and splitters in NMOSD: does it matter?
L-21 Novel biomarkers for NMO

*subject to change